vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and SYNAPTICS Inc (SYNA). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $302.5M, roughly 1.6× SYNAPTICS Inc). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -4.9%, a 11.7% gap on every dollar of revenue. On growth, SYNAPTICS Inc posted the faster year-over-year revenue change (13.2% vs -1.7%). Over the past eight quarters, SYNAPTICS Inc's revenue compounded faster (12.9% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Synaptics, Inc. is an American neural network technologies and computer-to-human interface devices development company based in San Jose, California. It develops touchpads and fingerprint biometrics technology for computer laptops; touch, display driver, and fingerprint biometrics technology for smartphones; and touch, video and far-field voice, low-power AI processors, and wireless technology for smart home devices, wearables, and automobiles. Synaptics sells its products to original equipme...
MD vs SYNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $302.5M |
| Net Profit | $33.7M | $-14.8M |
| Gross Margin | — | 43.5% |
| Operating Margin | 9.9% | -5.0% |
| Net Margin | 6.8% | -4.9% |
| Revenue YoY | -1.7% | 13.2% |
| Net Profit YoY | 10.5% | -922.2% |
| EPS (diluted) | $0.40 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $302.5M | ||
| Q3 25 | $492.9M | $292.5M | ||
| Q2 25 | $468.8M | $282.8M | ||
| Q1 25 | $458.4M | $266.6M | ||
| Q4 24 | $502.4M | $267.2M | ||
| Q3 24 | $511.2M | $257.7M | ||
| Q2 24 | $504.3M | $247.4M | ||
| Q1 24 | $495.1M | $237.3M |
| Q4 25 | $33.7M | $-14.8M | ||
| Q3 25 | $71.7M | $-20.6M | ||
| Q2 25 | $39.3M | $-4.7M | ||
| Q1 25 | $20.7M | $-21.8M | ||
| Q4 24 | $30.5M | $1.8M | ||
| Q3 24 | $19.4M | $-23.1M | ||
| Q2 24 | $-153.0M | $208.3M | ||
| Q1 24 | $4.0M | $-18.1M |
| Q4 25 | — | 43.5% | ||
| Q3 25 | — | 42.6% | ||
| Q2 25 | — | 43.0% | ||
| Q1 25 | — | 43.4% | ||
| Q4 24 | — | 45.7% | ||
| Q3 24 | — | 46.9% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | — | 46.5% |
| Q4 25 | 9.9% | -5.0% | ||
| Q3 25 | 13.8% | -7.9% | ||
| Q2 25 | 12.8% | -8.6% | ||
| Q1 25 | 7.0% | -9.9% | ||
| Q4 24 | 7.8% | -5.7% | ||
| Q3 24 | 6.6% | -11.0% | ||
| Q2 24 | -31.3% | -12.6% | ||
| Q1 24 | 3.2% | -7.3% |
| Q4 25 | 6.8% | -4.9% | ||
| Q3 25 | 14.5% | -7.0% | ||
| Q2 25 | 8.4% | -1.7% | ||
| Q1 25 | 4.5% | -8.2% | ||
| Q4 24 | 6.1% | 0.7% | ||
| Q3 24 | 3.8% | -9.0% | ||
| Q2 24 | -30.3% | 84.2% | ||
| Q1 24 | 0.8% | -7.6% |
| Q4 25 | $0.40 | $-0.38 | ||
| Q3 25 | $0.84 | $-0.53 | ||
| Q2 25 | $0.46 | $-0.13 | ||
| Q1 25 | $0.24 | $-0.56 | ||
| Q4 24 | $0.37 | $0.05 | ||
| Q3 24 | $0.23 | $-0.58 | ||
| Q2 24 | $-1.84 | $5.28 | ||
| Q1 24 | $0.05 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $437.4M |
| Total DebtLower is stronger | $570.5M | $836.0M |
| Stockholders' EquityBook value | $865.9M | $1.4B |
| Total Assets | $2.2B | $2.6B |
| Debt / EquityLower = less leverage | 0.66× | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $437.4M | ||
| Q3 25 | $340.1M | $459.9M | ||
| Q2 25 | $224.7M | $452.5M | ||
| Q1 25 | $99.0M | $421.4M | ||
| Q4 24 | $229.9M | $596.1M | ||
| Q3 24 | $103.8M | $853.6M | ||
| Q2 24 | $19.4M | $876.9M | ||
| Q1 24 | $8.0M | $828.6M |
| Q4 25 | $570.5M | $836.0M | ||
| Q3 25 | $577.2M | $835.4M | ||
| Q2 25 | $583.9M | $834.8M | ||
| Q1 25 | $590.5M | $834.2M | ||
| Q4 24 | $597.1M | $832.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $983.5M | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.4B | ||
| Q3 25 | $890.7M | $1.4B | ||
| Q2 25 | $833.8M | $1.4B | ||
| Q1 25 | $789.2M | $1.4B | ||
| Q4 24 | $764.9M | $1.4B | ||
| Q3 24 | $732.5M | $1.5B | ||
| Q2 24 | $706.5M | $1.5B | ||
| Q1 24 | $856.2M | $1.2B |
| Q4 25 | $2.2B | $2.6B | ||
| Q3 25 | $2.2B | $2.6B | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.0B | $2.6B | ||
| Q4 24 | $2.2B | $2.5B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.0B | $2.8B | ||
| Q1 24 | $2.2B | $2.5B |
| Q4 25 | 0.66× | 0.60× | ||
| Q3 25 | 0.65× | 0.60× | ||
| Q2 25 | 0.70× | 0.60× | ||
| Q1 25 | 0.75× | 0.60× | ||
| Q4 24 | 0.78× | 0.60× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $29.8M |
| Free Cash FlowOCF − Capex | — | $18.2M |
| FCF MarginFCF / Revenue | — | 6.0% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $154.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $29.8M | ||
| Q3 25 | $137.3M | $30.2M | ||
| Q2 25 | $137.2M | $57.2M | ||
| Q1 25 | $-117.5M | $73.4M | ||
| Q4 24 | $133.0M | $22.8M | ||
| Q3 24 | $91.8M | $-11.4M | ||
| Q2 24 | $107.0M | $65.0M | ||
| Q1 24 | $-125.2M | $-13.7M |
| Q4 25 | — | $18.2M | ||
| Q3 25 | — | $18.0M | ||
| Q2 25 | — | $50.6M | ||
| Q1 25 | — | $68.0M | ||
| Q4 24 | — | $18.1M | ||
| Q3 24 | — | $-20.5M | ||
| Q2 24 | — | $57.3M | ||
| Q1 24 | — | $-22.7M |
| Q4 25 | — | 6.0% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | 17.9% | ||
| Q1 25 | — | 25.5% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | — | -8.0% | ||
| Q2 24 | — | 23.2% | ||
| Q1 24 | — | -9.6% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 3.8% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 12.67× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 0.31× | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SYNA
| Enterprise And Automotive Product Applications | $161.1M | 53% |
| Internet Of Things Product Applications | $93.2M | 31% |
| Mobile Product Applications | $48.2M | 16% |
